Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Frontiers in Immunology|January 11, 2020
Salmonella Effector SteA Suppresses Proinflammatory Responses of the Host by Interfering With IκB DegradationAakanksha Gulati, Rhythm Shukla, Arunika Mukhopadhaya
Cureus|August 29, 2025
Vaccine-Associated Proteinase 3 Anti-neutrophil Cytoplasmic Antibodies (PR3-ANCA) Vasculitis: A Case Report and Review of Emerging EvidenceRhythm Shukla, Shivankur Singh, Huzefa Ansari
Frontiers in Microbiology|August 2, 2021
Brevibacillin 2V Exerts Its Bactericidal Activity via Binding to Lipid II and Permeabilizing Cellular MembranesXinghong Zhao, Xiaoqi Wang, Rhythm Shukla, et al.
Frontiers in Microbiology|July 5, 2021
Brevibacillin 2V, a Novel Antimicrobial Lipopeptide With an Exceptionally Low Hemolytic ActivityXinghong Zhao, Xiaoqi Wang, Rhythm Shukla, et al.
Research Square|April 8, 2024
A Resistance-Evading Antibiotic for Treating AnthraxDallas Hughes, William Lawrence, Jennifer Peel, et al.
ACS Infectious Diseases|February 27, 2025
Teixobactin: A Resistance-Evading Antibiotic for Treating AnthraxWilliam S Lawrence, Jennifer E Peel, Rosan de Winter, et al.
Nature Communications|June 7, 2020
Mode of action of teixobactins in cellular membranesRhythm Shukla, João Medeiros-Silva, Anish Parmar, et al.
Life Science Alliance|August 17, 2023
A novel antifolate suppresses growth of FPGS-deficient cells and overcomes methotrexate resistanceFelix van der Krift, Dick W Zijlmans, Rhythm Shukla, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2023
A new antibiotic from an uncultured bacterium binds to an immutable targetRhythm Shukla, Aaron J Peoples, Kevin C Ludwig, et al.
Nature|August 3, 2022
Teixobactin kills bacteria by a two-pronged attack on the cell envelopeRhythm Shukla, Francesca Lavore, Sourav Maity, et al.
Pageof 2